Mucosal delivery of sumatriptan: ATRX filed an IND to begin a Phase I of its sumatriptan

Atrix Laboratories Inc. (ATRX), Fort

Read the full 54 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE